Innovative Medicines Canada is calling on the federal government to introduce amendments to Bill C-64 that clarify the impact on all aspects of Canadians’ drug coverage. In a press release, the association urged the feds to ensure its new pharmacare program doesn’t disrupt existing coverage for the 27 million Canadians who are insured under a […]
The World Health Organization defines a rare disease as having a prevalence of 65 or less per 100,000 individuals. It recognizes some 5,500 rare diseases, the majority being of genetic origin and often life-threatening. Medical research has yielded significant drug development for the treatment of rare diseases, increasing life expectancy and improving quality of life. However, […]
An article outlining the implications of a single-payer universal pharmacare system was the most-read story on BenefitsCanada.com this week. Here are the top five human resources, benefits, pension and investmnet stories of the past week: 1. Sounding Board: What plan sponsors should know about pharmacare 2. Meet the 2024 Workplace Benefits Awards judges 3. Mental-health claims by Canadians up […]
Plan sponsors worried about the expense and sustainability of their drug plan might initially embrace a pharmacare plan, hoping to shift drug costs to a new program funded by provincial and federal governments. However, this may not be the solution it seems. A single-payer universal pharmacare system might limit medication access for individuals with employer-sponsored benefits […]
The federal government’s pharmacare bill is headed to the Senate after passing third reading in the House of Commons. The bill was the result of careful and lengthy negotiations between the Liberals and the New Democratic Party as a key element of their political pact to prevent an early election. Read: Liberals table bill paving way […]
While the concept behind the federal government’s universal pharmacare plan is well intentioned, the program would make a larger impact for employers by focusing on high-cost and specialty drugs, says Pam Martin, vice-president and senior consultant at Baynes & White Inc. In theory, the way that the government is rolling out the program in small […]
In its 2024 budget on Tuesday, the federal government announced a new working group dedicated to encouraging increased domestic investments by Canadian institutional investors. Former Bank of Canada governor Stephen Poloz is being tasked to lead an organization that will identify priority investment opportunities in the country for the more than $3 trillion held by […]
Health Minister Mark Holland tabled a long-awaited bill Thursday meant to pave the way for national pharmacare and preserve a deal that secures the New Democratic Party’s support for the government in the House of Commons. The bill includes a program to cover birth control as well as diabetes drugs and supplies for anyone with […]